Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 November 2024 | Story Jacky Tshokwe | Photo Supplied
Dr Mariana Erasmus
Dr Mariana Erasmus (Vice Director, CMBG) demonstrates some of the equipment in the newly established, state-of-the-art laboratories at the Centre for Mineral Biogeochemistry.

The University of the Free State (UFS) recently hosted a landmark event-the national launch of the South African Biogeochemistry Research Infrastructure Platform (BIOGRIP) - in the Centenary Complex on its Bloemfontein Campus. This significant occasion marked the establishment of the Centre for Mineral Biogeochemistry at the UFS and underscored South Africa’s growing commitment to biogeochemistry research.

Prof Anthea Rhoda welcomed the distinguished gathering of scientists, students, industry leaders, and stakeholders, highlighting the launch as a collaborative milestone in South Africa's scientific journey. In her address, Prof Rhoda emphasised the importance of the interdisciplinary nature of biogeochemistry, where biology, geology, and chemistry converge to offer insights into critical issues such as climate change, water quality, and soil health. She remarked on the necessity of collaboration, explaining that BIOGRIP’s platform, built on shared resources and expertise, exemplifies the power of uniting across institutional boundaries to accelerate impactful discoveries.

The programme featured insightful scientific talks by leading experts, each focusing on how biogeochemistry addresses key environmental issues such as sustainability and resource management. These presentations reinforced BIOGRIP’s commitment to advancing knowledge that can influence policy and improve practices.

Attendees were also given guided tours of the state-of-the-art laboratories in the Centre for Mineral Biogeochemistry, which provided a behind-the-scenes look at the advanced tools and methods employed in studying interactions between minerals, biology, and the environment. For many, this was a highlight, as they observed firsthand how biogeochemical research is conducted and contributes to soil health, pollution control, and environmental conservation.

The launch provided ample networking opportunities, fostering connections among academics, government representatives, industry professionals, and environmental organisations. Over a catered lunch, participants engaged in vibrant discussions about potential collaborations and the role of biogeochemistry in addressing South Africa’s environmental challenges.

The BIOGRIP national launch stands as a milestone event, not only for the UFS, but for the broader South African scientific community. With the establishment of this research platform, South Africa is well-positioned to tackle pressing environmental issues through innovative research and cross-sector collaboration. The event left attendees inspired and motivated, setting an optimistic tone for the future of biogeochemistry research in the region.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept